[1]孙光丽,姜静,王成虎,等.高密度微脉冲激光联合玻璃体内注射雷珠单抗治疗糖尿病性黄斑水肿[J].眼科新进展,2017,37(3):279-281.[doi:10.13389/j.cnki.rao.2017.0070]
　SUN Guang-Li,JIANG Jing,WANG Cheng-Hu,et al.High-density micropulse photocoagulation combined with intravitreal injection of ranibizumab for diabetic macular edema[J].Recent Advances in Ophthalmology,2017,37(3):279-281.[doi:10.13389/j.cnki.rao.2017.0070]
点击复制

高密度微脉冲激光联合玻璃体内注射雷珠单抗治疗糖尿病性黄斑水肿/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
37卷
期数:
2017年3期
页码:
279-281
栏目:
应用研究
出版日期:
2017-03-05

文章信息/Info

Title:
High-density micropulse photocoagulation combined with intravitreal injection of ranibizumab for diabetic macular edema
作者:
孙光丽; 姜静; 王成虎; 张舒; 姚进
210000　江苏省南京市，南京医科大学附属眼科医院
Author(s):
SUN Guang-Li; JIANG Jing; WANG Cheng-Hu; ZHANG Shu; YAO Jin
Eye Hospital，Nanjing Medical University，Nanjing 210000，Jiangsu Province，China
关键词:
糖尿病性黄斑水肿; 雷珠单抗; 高密度微脉冲激光
Keywords:
diabetic macular edema; ranibizumab; high-density micropulse photocoagulation
分类号:
R774.5
DOI:
10.13389/j.cnki.rao.2017.0070
文献标志码:
A
摘要:
目的　观察高密度微脉冲激光联合玻璃体内注射雷珠单抗治疗糖尿病性黄斑水肿（diabetic macular edema，DME）的疗效。方法　将31例（31眼）DME患者分2组，A组15例（15眼）行高密度微脉冲激光联合玻璃体内注射雷珠单抗治疗；B组16例（16眼）仅行玻璃体内注射雷珠单抗治疗。观察治疗前后黄斑中心凹视网膜厚度（central macular thickness，CMT）、最佳矫正视力（best corrected visual acuity,BCVA），以及两组各自雷珠单抗的年平均注射次数。结果　雷珠单抗年注射次数：A组为（3.67±1.11）次，B组为（9.12±2.63）次，两组相比差异有统计学意义（t=2.05，P<0.05）。两组治疗后CMT均较治疗前降低，差异均有统计学意义（均为P<0.05），但两组治疗前后CMT差值比较差异无统计学意义（t=1.19，P>0.05）。两组治疗后BCVA均较治疗前有所改善，且差异均有统计学意义（均为P<0.05），但两组之间治疗前后BCVA相比差异均无统计学意义（均为P>0.05）。结论　高密度微脉冲激光联合玻璃体内注射雷珠单抗与单纯玻璃体内注射雷珠单抗均可有效治疗DME，但前者可以明显减少雷珠单抗的注射次数，患者依从性较好，是治疗DME的一种较好选择。
Abstract:
Objective　To investigate the clinical effects of high-density micropulse photocoagulation（HD-SDM）combined with intravitreal injection of ranibizumab for diabetic macular edema(DME).Methods　Thirty-one patients (31 eyes) with DME were randomly divided into two groups.Group A (15 eyes) received HD-SDM combined with intravitreal injection of ranibizumab.Group B (16 eyes) only received intravitreal injection of ranibizumab.The best corrected visual acuity (BCVA) and central macular thickness (CMT) of the two groups before and after treatment were analyzed,and the annual injection times of the two groups were compared.Results　The average annual injection times was 3.67±1.11 in group A,and 9.12±2.63 in group B.The difference was significant between the two groups (t=2.05,P<0.05).There were significant differences in CMT before and after treatment in both groups (all P<0.05).There was no significant difference in CMT between the two groups(t=1.19,P>0.05).There were significant differences in BCVA before and after treatment in both groups(all P<0.05),but there was no significant difference before and after treatment between the two groups(all P>0.05).Conclusion　Both HD-SDM combined with intravitreal injection of ranibizumab and single intravitreal injection of ranibizumab are effective for DME,but the combining treatment can remarkably decrease the annual injection times and had a good compliance of patients,is a good choice for DME patients.

参考文献/References:

［1］　EARLY TREATMENT DIABETIC RETINOPATHY STUDY RESEARCH GROUP.Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema.Early Treatment Diabetic Retinopathy Study Report Number 2［J］.Ophthalmology，1987，94（7）：761-774.
［2］　ZHANG X，ZENG H，BAO S，WANG N，GILLIES MC.Diabetic macular edema：new concepts in patho-physiology and treatment［J］.Cell Biosci，2014（Suppl 1）：27.
［3］　NICHOLSON BP，SCHACHAT AP.A review of clinical trials of anti-VEGF agents for diabetic retinopathy［J］.Graefes Arch Clin Exp Ophthalmol，2010，248（7）：915-930.
［4］　KLEIN R，KLEIN BE，MOSS SE.Visual impairment in diabetes［J］.Ophthalmology，1984，91（1）：1-9.
［5］　FUNASTU H，YAMASHITA H，IKEDA T，NAKANISHI Y，KITANO S.Angiotension II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorder［J］.Am J Ophthalmol，2002，133（4）：537-543.
［6］　LI J，CUI Y，WANG Q，GUO D，PAN X，WANG X，et al.The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1［J］.Mol Vis，2014，20（13）：649-660.
［7］　NGUYEN QD，TATLIPINAR S，SHAH SM，HALLER JA，QUINLAN E，SUNG J，et al.Vascular endothelial growth factor is a critical stimulus for diabetic macular edema［J］.Am J Ophthalmol，2006，142（6）：961-969.
［8］　MITCHELL P，BANDELLO F，SCHMIDT-ERFURTH U，LANG GE，MASSIN P，SCHLINGEMANN RO，et al.The RESTORE study：ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema［J］.Ophthalmology，2011，118（4）：615-625.
［9］　CHEN HX，CLECK JN.Adverse effects of anticancer agents that target the VEGF pathway［J］.Nat Rev Clin Oncol，2009，6（8）：465-477.
［10］　陈静，赖铭莹，罗恒，佘洁婷.抗VEGF药物联合激光光凝治疗糖尿病性黄斑水肿观察研究［J］.中国实用眼科杂志，2014，32（6）：693-697.
CHEN J，LAI MY，LUO H，SHE JT.Clinical study on anti-VEGF plus photocoagulation for diabetic macular edema［J］.Chin J Pract Ophthalmol，2014，32（6）：693-697.
［11］　李涛，罗清礼，吴海英.人视网膜激光光凝后荧光血管造影和超微结构研究［J］.四川大学学报（医学版），2004，35（2）：234-237.
LI T，LUO QL，WU HY.Histopathologic and immunohistochemical studies on retina after laser photocoagulation［J］.J Sichuan Univ （Med Sci Edi），2004，35（2）：234-237.
［12］　SCHATZ H，MADERIA D，MCDONALD HR，JOHNSON RN.Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema［J］.Arch Ophthlmol，1991，109（11）：1549-1551.
［13］　AKDUMAN L，OLK RJ.Laser photocoagulation of diabetic macular edema［J］.Ophthalmic Surg Lasers，1997，28（5）：387-408.
［14］　LUTTRULL JK，MUSCH DC，MAINSTER MA.Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular edema［J］.Br J Ophthalmol，2005，89（1）：74-80.
［15］　ROIDER J，MICHAUD N，FLOTTE T，BIRNGRUBER R.Histology of retinal lesions after continuous irradiation and selective micro-coagulation of the retinal pigment epithelium［J］.Ophthalmologe，1993，90（3）：274-278.
［16］　FRIBERG TR，KARATZA EC.The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser［J］.Ophthalmology，1997，104（12）：2030-2038.
［17］　LAVINSKY D，CARDILLO JA，MELO LA，DARE A，FARAB ME.Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema［J］.Invest Ophthalmol Vis Sci，2011，52（7）：4314-4323.

相似文献/References:

[1]麻南 李丹 高付林 胡莲娜.玻璃体内注射贝伐单抗和贝伐单抗/曲安奈德联合用药治疗糖尿病性黄斑水肿疗效及安全性差异的荟萃分析[J].眼科新进展,2012,32(6):000.
[2]李姣 王兴荣 崔彦 刘正峰 王影 李洋.雷珠单抗选择性体外抑制睫状体恶性黑色素瘤[J].眼科新进展,2013,33(11):000.
[3]王玲,生侠,吴清静,等.红外线及自发荧光影像在糖尿病性黄斑水肿诊断中的价值[J].眼科新进展,2014,34(8):754.[doi:10.13389/j.cnki.rao.2014.0207]
　WANG Ling,SHENG Xia,WU Qing-Jing,et al.Value of infrared ray and auto fluorescence in diagnosis of diabetic macular edema[J].Recent Advances in Ophthalmology,2014,34(3):754.[doi:10.13389/j.cnki.rao.2014.0207]
[4]金昱,石安娜,刘淼. 玻璃体内注射雷珠单抗（Ranibizumab）治疗视网膜静脉阻塞继发黄斑水肿[J].眼科新进展,2014,34(9):855.[doi:10.13389/j.cnki.rao.2014.0236]
[5]张聪,刘东宁,徐丽. 玻璃体内注射Lucentis治疗中心性渗出性脉络膜视网膜病变的临床疗效[J].眼科新进展,2014,34(9):864.[doi:10.13389/j.cnki.rao.2014.0239]
[6]章晖,叶波,邱新文,等.雷珠单抗辅助23G玻璃体切割术治疗增生性糖尿病视网膜病变[J].眼科新进展,2014,34(10):975.[doi:10.13389/j.cnki.rao.2014.0270]
[7]王博,吴京,马明,等. 玻璃体内注射雷珠单抗与曲安奈德治疗糖尿病黄斑水肿的疗效对比分析[J].眼科新进展,2015,35(3):246.[doi:10.13389/j.cnki.rao.2015.0066]
　WANG Bo,WU Jing,MA Ming,et al. Clinictid effect comparison of intravitreal lucentis and triamcinolone acetonide for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(3):246.[doi:10.13389/j.cnki.rao.2015.0066]
[8]刘斌,杨玉霞,刘杏,等. 雷珠单抗联合Ahmed青光眼阀植入术治疗新生血管性青光眼[J].眼科新进展,2015,35(3):263.[doi:10.13389/j.cnki.rao.2015.0070]
　LIU Bin,YANG Yu-Xia,LIU Xing,et al. Intravitreal lucentis injection combined with Ahmed valve implantation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(3):263.[doi:10.13389/j.cnki.rao.2015.0070]
[9]刘志南,邓国华,江一. 光凝前雷珠单抗玻璃体内注射对CNV患者黄斑区视网膜及视功能的影响[J].眼科新进展,2015,35(4):365.[doi:10.13389/j.cnki.rao.2015.0098]
　LIU Zhi-Nan,DENG Guo-Hua,JIANG Yi. Effects of ranibizumab intravitreal injection before photocoagulation on macular retina and visual function in patients with CNV[J].Recent Advances in Ophthalmology,2015,35(3):365.[doi:10.13389/j.cnki.rao.2015.0098]
[10]杨宇,田敏,吕红彬. 糖尿病视网膜病变的治疗进展[J].眼科新进展,2015,35(5):497.[doi:10.13389/j.cnki.rao.2015.0136]
　YANG Yu,TIAN Min,LV Hong-Bin. Recent advances in treatment of diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(3):497.[doi:10.13389/j.cnki.rao.2015.0136]
[11]李素华,高永峰. 比较单独黄斑局灶/格栅样光凝术和联合雷珠单抗治疗糖尿病性黄斑水肿的疗效[J].眼科新进展,2015,35(6):566.[doi:10.13389/j.cnki.rao.2015.0153]
　LI Su-Hua,GAO Yong-Feng. Efficacy of macular focal / grid photocoagulation combined with ranibizumab for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(3):566.[doi:10.13389/j.cnki.rao.2015.0153]

更新日期/Last Update: 2017-04-01